Literature DB >> 2434861

Relaxin affects the release of oxytocin and vasopressin from the neurohypophysis.

G Dayanithi, M Cazalis, J J Nordmann.   

Abstract

The hormone relaxin has recently been shown to inhibit not only uterine muscle contraction, but also the release of oxytocin into the plasma. Intravenous injection of porcine relaxin in anaesthetized lactating rats inhibits milk ejection and injection of relaxin into the cerebral ventricles disturbs the pattern of the milk ejection reflex. Recent experiments performed in vivo indicate that relaxin might act not only in the uterus, but also in the hypothalamus and possibly in the neurohypophysis. We tested this hypothesis in vitro by studying the effect of relaxin on hormone release from isolated neural lobes of the pituitary and isolated neurosecretory nerve endings of the neurohypophysis from the rat. We report here that relaxin has a dual effect on neurohypophysial hormone secretion. Under basal conditions, vasopressin and oxytocin release was inhibited by relaxin but, when the nerve endings were depolarized, vasopressin and oxytocin secretion was potentiated. We also found that relaxin acts at a stage before the increase in cytoplasmic free Ca2+ that is necessary for inducing hormone release, possibly by gating the calcium channel.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2434861     DOI: 10.1038/325813a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  8 in total

Review 1.  Relaxin family peptide systems and the central nervous system.

Authors:  G E Callander; R A D Bathgate
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

Review 2.  Modulation/physiology of calcium channel sub-types in neurosecretory terminals.

Authors:  José R Lemos; Sonia I Ortiz-Miranda; Adolfo E Cuadra; Cristina Velázquez-Marrero; Edward E Custer; Taimur Dad; Govindan Dayanithi
Journal:  Cell Calcium       Date:  2012-02-17       Impact factor: 6.817

3.  Quantitative autoradiographic studies of relaxin binding in rat atria, uterus and cerebral cortex: characterization and effects of oestrogen treatment.

Authors:  Y Y Tan; J D Wade; G W Tregear; R J Summers
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

4.  Inotropic responses to human gene 2 (B29) relaxin in a rat model of myocardial infarction (MI): effect of pertussis toxin.

Authors:  Andrew R Kompa; Chrishan S Samuel; Roger J Summers
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

5.  Autoradiographic localization of relaxin binding sites in rat brain.

Authors:  P L Osheroff; H S Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

6.  Relaxin binding in the rat heart atrium.

Authors:  P L Osheroff; M J Cronin; J A Lofgren
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

7.  Specific expression of an oxytocin-enhanced cyan fluorescent protein fusion transgene in the rat hypothalamus and posterior pituitary.

Authors:  Akiko Katoh; Hiroaki Fujihara; Toyoaki Ohbuchi; Tatsushi Onaka; W Scott Young; Govindan Dayanithi; Yuka Yamasaki; Mitsuhiro Kawata; Hitoshi Suzuki; Hiroki Otsubo; Hideaki Suzuki; David Murphy; Yoichi Ueta
Journal:  J Endocrinol       Date:  2009-12-21       Impact factor: 4.286

8.  Physiology of spontaneous [Ca(2+)]i oscillations in the isolated vasopressin and oxytocin neurones of the rat supraoptic nucleus.

Authors:  Stepan Kortus; Chinnapaiyan Srinivasan; Oksana Forostyak; Yoichi Ueta; Eva Sykova; Alexandr Chvatal; Martin Zapotocky; Alexei Verkhratsky; Govindan Dayanithi
Journal:  Cell Calcium       Date:  2016-04-06       Impact factor: 6.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.